AstraZeneca To Appeal $215M Drug Pricing Verdict
AstraZeneca Pharmaceuticals LP has vowed to appeal a verdict handed down by an Alabama jury Thursday that ordered the drug company to pay $215 million in damages for allegedly overcharging Medicaid...To view the full article, register now.
Already a subscriber? Click here to view full article